![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
Follow-Up on Medicine and Profit
Feb. 15th, 2006 09:45 amA Cancer Drug Shows Promise, at a Price That Many Can't Pay
By ALEX BERENSON
Genentech plans to charge about $100,000 a year for the drug Avastin as a treatment for breast and lung cancer.
( Cut for Full Text )
By ALEX BERENSON
Genentech plans to charge about $100,000 a year for the drug Avastin as a treatment for breast and lung cancer.
( Cut for Full Text )
